ReviewWorld journal of hepatology2025

Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management.

Kadek Mercu Narapati Pamungkas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.